Which physician groups promoted ivermectin and what are their institutional and political affiliations?

Checked on February 3, 2026
Disclaimer: Factually can make mistakes. Please verify important information or breaking news. Learn more.

Executive summary

Two physician-led groups—America’s Frontline Doctors (AFLDS) and the Front Line COVID-19 Critical Care Alliance (FLCCC), now styled in some sources as the Independent Medical Alliance—were the most visible organized promoters of ivermectin as a COVID-19 (and later non-COVID) therapy, and both combined medical rhetoric with networks tied to conservative and right‑wing political movements and media ecosystems [1] [2] [3]. Federal and international public-health bodies warned against ivermectin for COVID-19 outside trials, even as these physician groups and allied clinicians pushed off‑label prescribing, telemedicine consults, and political advocacy to broaden access [4] [5] [6].

1. AFLDS: a small physician group embedded in conservative political networks

America’s Frontline Doctors (AFLDS), founded by Dr. Simone Gold, became a prominent public face for ivermectin promotion and broader anti‑vaccine and contrarian COVID messaging; reporting ties AFLDS to the Free Speech Foundation and political backers such as the Tea Party Patriots, and documents show AFLDS leaders expanding claims beyond COVID to other illnesses while monetizing telehealth and publicity channels [3] [1] [7]. AFLDS’s activity was not confined to academic institutions; it operated through media appearances, conservative networks, and telemedicine services that charged patients for consultations and prescriptions—moves that critics say turned medical dissent into a political and commercial project [7] [1].

2. FLCCC / Independent Medical Alliance: clinicians turned advocacy organization

The Front Line COVID-19 Critical Care Alliance (FLCCC), led by physicians including Pierre Kory and Paul Marik, originated as a clinician group but became a sustained promoter of ivermectin, first for COVID-19 and later for other respiratory illnesses, shifting into an advocacy and information network after many members left hospital positions or faced professional pushback [5] [2] [1]. FLCCC’s scientific claims were contested by mainstream reviews and trial evidence, and the organization has been described in reporting and encyclopedic summaries as advocating “unapproved, dubious, and ineffective treatments” while its leaders moved into conservative media and political forums [5] [2].

3. Institutional standing and credential consequences

Several prominent promoters associated with these groups lost institutional footholds or faced disciplinary actions as a result of their advocacy: reporting indicates that leaders like Kory and Marik had their board certifications revoked for promoting unproven treatments and vaccine skepticism, and FLCCC founders were expelled from or left hospital positions as they amplified ivermectin claims [2] [8]. At the same time, other physician organizations and major professional societies opposed compelled ivermectin use, and hospital systems and medical boards argued for evidence‑based standards, highlighting an institutional split between fringe physician groups and mainstream medicine [9] [4].

4. Political alignment, media amplification, and monetization

The ivermectin movement’s momentum depended on amplification through conservative and celebrity media: AFLDS and some FLCCC figures cultivated relationships with right‑leaning platforms and personalities that spread anecdote over evidence, while charging for telehealth visits that could provide prescriptions—an interplay of political affinity, media reach, and revenue that helped sustain promotion even as scientific trials produced mixed or negative results [3] [1] [7]. State‑level politics also intersected with this advocacy: reporting and policy monitoring show legislative efforts to expand access to ivermectin and ongoing social media campaigns reframing the drug as a panacea, especially in conservative circles [10].

5. The contested evidence and alternative viewpoints

Proponents pointed to early in vitro work and selective studies suggesting antiviral activity and to a handful of clinical reports as support for ivermectin’s use, while major randomized trials and systematic reviews generally found no reliable, clinically meaningful benefit and warned of bias in positive studies; regulators including the FDA and agencies such as WHO advised against routine use outside trials, a scientific counterweight that advocates often dismissed as part of an establishment consensus [6] [5] [11]. Reporting also records a minority of physicians and some patients who defended off‑label prescribing as within clinical discretion, underscoring that the debate involved contrasting judgments about evidence thresholds, clinical autonomy, and political distrust [4] [12] [9].

Conclusion: mapping promoters and their affiliations

In short, the principal organized physician promoters of ivermectin identified in contemporary reporting were AFLDS and the FLCCC/Independent Medical Alliance; both blended medical claims with ties to conservative political networks, right‑leaning media amplification, and commercial telemedicine activity, and both stood in conflict with mainstream medical institutions and regulatory guidance that cautioned against ivermectin for COVID‑19 outside rigorous trials [1] [2] [3] [4] [5].

Want to dive deeper?
Which state laws or bills have aimed to expand access to ivermectin and who sponsored them?
What evidence and trials most influenced mainstream medical agencies to reject ivermectin for COVID-19?
How did telemedicine and online consultations factor into the distribution and prescription patterns for ivermectin?